Use of Nesiritide in the Management of Acute Diastolic Heart Failure
Status:
Terminated
Trial end date:
2006-04-24
Target enrollment:
Participant gender:
Summary
Primary objective is to assess the effect of nesiritide in decreasing left ventricular (LV)
filling pressure, defined as pulmonary artery capillary wedge pressure (PCWP) in a group of
patients admitted with acute diastolic heart failure.
Secondary objectives include: improvement in symptoms, exercise tolerance, improvement in
Doppler diastolic filling parameters in patients with diastolic heart failure.